On May 17, the federal government told six drug companies that their 340B contract pharmacy policies were illegal, and it asked them to provide updates by June 1 on their plans to comply with the law.
At least three of the six sent back defiant responses, and five of the six are still suing the government over its conclusion that their restrictions on 340B pricing in the contract pharmacy setting have resulted in illegal overcharges and must stop immediately.
On May 17, the federal government told six drug companies that their 340B contract pharmacy policies were illegal, and it asked them to provide updates by June 1 on their plans to comply with the law.
At least three of the six sent back defiant responses.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.